Khiron Life Sciences Corp. (KHRNF)

USD 0.0

(0.0%)

Market Cap (In USD)

502.04 Million

Revenue (In USD)

12.79 Million

Net Income (In USD)

-33.12 Million

Avg. Volume

80.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-6-0.02
PE
-
EPS
-
Beta Value
15.429
ISIN
CA49374L3065
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Alvaro Francisco Torres
Employee Count
-
Website
https://khiron.ca
Ipo Date
2021-01-08
Details
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.